Proliferation of Hepatic Oval Cells via Cyclooxygenase-2 and Extracellular Matrix Protein Signaling during Liver Regeneration Following 2-AAF/Partial Hepatectomy in Rats
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: In the 2-acetylaminofluorene (2-AAF)/ 70% partial hepatectomy (PHx) model, the mechanism underlying the differentiation of activated hepatic oval cells (HOCs) into hepatocytes and bile ductile cells is unclear. We investigated the role of cyclooxygenase-2 (COX-2) in HOCs and the relationship between COX-2 and extracellular matrix proteins in cellular proliferation. Methods: Reverse transcription-polymerase chain reaction, immunohistochemical staining, and Western blotting were used to assess COX-2 expression. The co-localization of COX-2 with Thy1, c-Met, epithelial cell adhesion molecule, and a-smooth muscle actin was also examined. Additionally, we investigated whether connective tissue growth factor (CTGF), fibronectin (FN), extracellular signal-regulated kinase 1/2 (P-ERK1/2), and AKT were expressed in HOCs. Results: The expression of COX-2, prostaglandin E2 receptors, and c-Met was upregulated in HOCs. However, HOCs treated with the COX-2 inhibitor NS398 showed decreased COX-2, CTGF, FN, and AKT expression, whereas P-ERK1/2 was unaffected. Additionally, NS398 inhibited HOC proliferation, but not the proliferation of HOCs cultured on FN-coated dishes. Furthermore, the proliferative response of HOCs treated with NS398 was reversed by hepatic growth factor treatment. Conclusions: These results suggest that HOC proliferation is mediated through COX-2, extracellular FN expression, and AKT activation. Thus, COX-2 plays an important role in HOC proliferation following acute injury.
Abstract
Background/Aims: In the 2-acetylaminofluorene (2-AAF)/ 70% partial hepatectomy (PHx) model, the mechanism underlying the differentiation of activated hepatic oval cells (HOCs) into hepatocytes and bile ductile cells is unclear. We investigated the role of cyclooxygenase-2 (COX-2) in HOCs and the relationship between COX-2 and extracellular matrix proteins in cellular proliferation. Methods: Reverse transcription-polymerase chain reaction, immunohistochemical staining, and Western blotting were used to assess COX-2 expression. The co-localization of COX-2 with Thy1, c-Met, epithelial cell adhesion molecule, and a-smooth muscle actin was also examined. Additionally, we investigated whether connective tissue growth factor (CTGF), fibronectin (FN), extracellular signal-regulated kinase 1/2 (P-ERK1/2), and AKT were expressed in HOCs. Results: The expression of COX-2, prostaglandin E2 receptors, and c-Met was upregulated in HOCs. However, HOCs treated with the COX-2 inhibitor NS398 showed decreased COX-2, CTGF, FN, and AKT expression, whereas P-ERK1/2 was unaffected. Additionally, NS398 inhibited HOC proliferation, but not the proliferation of HOCs cultured on FN-coated dishes. Furthermore, the proliferative response of HOCs treated with NS398 was reversed by hepatic growth factor treatment. Conclusions: These results suggest that HOC proliferation is mediated through COX-2, extracellular FN expression, and AKT activation. Thus, COX-2 plays an important role in HOC proliferation following acute injury.
참고문헌 (51)
- Michalopoulos GK, "Liver regeneration", Science, 276, pp.60~66 (1997)
- Fausto N, "The role of hepatocytes and oval cells in liver regeneration and repopulation", Mech Dev, 120, pp.117~130 (2003)
- Shafritz DA, "Liver stem cells and model systems for liver repopulation", J Hepatol, 36, pp.552~564 (2002)
- Evarts RP, "In vivo differentiation of rat liver oval cells into hepatocytes", Cancer Res, 49, pp.1541~1547 (1989)
- Petersen BE, "Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats", Hepatology, 27, pp.1030~1038 (1998)
- Thorgeirsson SS, "Hepatic stem cells in liver regeneration", FASEB J, 10, pp.1249~1256 (1996)
- Petersen BE, "Hepatic oval cellsexpress the hematopoietic stem cell marker Thy-1 in the rat", Hepatology, 27, pp.433~445 (1998)
- Sahin MB, "Isolation and characterization of a novel population of progenitor cells from unmanipulated rat liver", Liver Transpl, 14, pp.333~345 (2008)
- Goldschneider I, "Demonstration of Thy-1 antigen on pluripotent hemopoietic stem cells in the rat", J Exp Med, 148, pp.1351~1366 (1978)
- Craig W, "Expression of Thy-1 on human hematopoietic progenitor cells", J Exp Med, 177, pp.1331~1342 (1993)
- Bae SH, "Thy1-positive bone marrow stem cells express liver-specific genes in vitro and can mature into hepatocytes in vivo", Hepatol Int, 2, pp.63~71 (2008)
- Pi L, "Role of connective tissue growth factor in oval cell response during liver regeneration after 2-AAF", PHx in rats, 2005, pp.128, 2077~2088
- Yovchev MI, "Identification of adult hepatic progenitor cells capable of repopulating injured rat liver", Hepatology, 47, pp.636~647 (2008)
- Hla T, "Human cyclooxygenase-2 cDNA", Proc Natl Acad Sci U S A, 89, pp.7384~7388 (1992)
- Wen PZ, "Chromosomal organization of the inducible and constitutive prostaglandin synthase", cyclooxygenase genes in mouse, 1993, pp.(15), 458~460
- Funk CD, "Human platelet", erythroleukemia cell prostaglandin G, FASEB J, pp.1991, 5[DOI]
- Lee SH, "Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide", J Biol Chem, 267, pp.25934~25938 (1992)
- Jones DA, "Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines", J Biol Chem, 268, pp.9049~9054 (1993)
- Fletcher BS, "Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G", H synthase, 1992, pp.267, 4338~4344
- Hamasaki Y, "Phorbol ester and epidermal growth factor enhance the expression of two inducible prostaglandin H synthase genes in rat tracheal epithelial cells", Arch Biochem Biophys, 304, pp.226~234 (1993)
- Fosslien E, "Molecular pathology of cyclooxygenase-2 in neoplasia", Ann Clin Lab Sci, 30, pp.3~21 (2000)
- Davies RA, "Hepatic oval cell response to the choline-deficient, ethionine supplemented model of murine liver injury is attenuated by the administration of a cyclo-oxygenase 2 inhibitor", Carcinogenesis, 27, pp.1607~1616 (2006)
- Marsden ER, "Expression of acidic fibroblast growth factor in regenerating liver and during hepatic differentiation", Lab Invest, 67, pp.427~433 (1992)
- Nakamura T, "Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats", Biochem Biophys Res Commun, 122, pp.1450~1459 (1984)
- Schmidt C, "Scatter factor", hepatocyte growth factor is essential for liver development, 1995, pp.373, 699~702
- Bottaro DP, "Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product", Science, 251, pp.802~804 (1991)
- Tsukada Y, "High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2", J Biol Chem, 276, pp.40968~40976 (2001)
- Li G, "Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development", Oncogene, 20, pp.8125~8135 (2001)
- Webster CR, "Phosphoinositide 3-kinase, but not mitogen-activated protein kinase, pathway is involved in hepatocyte growth factor-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes", Hepatology, 33, pp.608~615 (2001)
- Yin L, "Participation of different cell types in the restitutive response of the rat liver to periportal injury induced by allyl alcohol", J Hepatol, 31, pp.497~507 (1999)
- Pi L, "Connective tissue growth factor with a novel fibronectin binding site promotes cell adhesion and migration during rat oval cell activation", Hepatology, 47, pp.996~1004 (2008)
- Han S, "Extracellular matrix fibronectin increases prostaglandin E2 receptor subtype EP4 in lung carcinoma cells through multiple signaling pathways: the role of AP-2", J Biol Chem, 282, pp.7961~7972 (2007)
- Han S, "Fibronectin stimulates human lung carcinoma cell growth by inducing cyclooxygenase-2 (COX-2) expression", Int J Cancer, 111, pp.322~331 (2004)
- Parker J, "Prostaglandin H synthase expression is variable in human colorectal adenocarcinoma cell lines", Exp Cell Res, 236, pp.321~329 (1997)
- Oh SH, "Hepatocyte growth factor induces differentiation of adult rat bone marrow cells into a hepatocyte lineage in vitro", Biochem Biophys Res Commun, 279, pp.500~504 (2000)
- Sum EY, "Loss of the LIM domain protein Lmo4 in the mammary gland during pregnancy impedes lobuloalveolar development", Oncogene, 24, pp.4820~4828 (2005)
- Bae SH, "Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398", Clin Cancer Res, 7, pp.1410~1418 (2001)
- Oh SH, "Bone marrow-derived hepatic oval cells differentiate into hepatocytes in 2-acetylaminofluorene", partial hepatectomy-induced liver regeneration, 2007, pp.132, 1077~1087
- Regan JW, "EP2 and EP4 prostanoid receptor signaling", Life Sci, 74, pp.143~153 (2003)
- Mutoh M, "Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis", Cancer Res, 62, pp.28~32 (2002)
- Jobin C, "Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells", Immunology, 95, pp.537~543 (1998)
- Lowes KN, "Upregulation of lymphotoxin beta expression in liver progenitor (oval) cells in chronic hepatitis C", Gut, 52, pp.1327~1331 (2003)
- Okano J, "Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K", AKT signaling pathway, 2003, pp.309, 298~304
- Okabe M, "Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver", Development, 136, pp.1951~1960 (2009)
- Reddy BS, "Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis", Cancer Res, 56, pp.4566~4569 (1996)
- Baek JY, "Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest", World J Gastroenterol, 13, pp.1175~1181 (2007)
- Baatar D, "Selective cyclooxygenase-2 blocker delays healing of esophageal ulcers in rats and inhibits ulceration-triggered c-Met", hepatocyte growth factor receptor in duction and extracellular signal-regulated kinase 2 activation, 2002, pp.160, 963~972
- Oh SH, "Hepatocyte growth factor induces differentiation of adult rat bone marrow cells into a hepatocyte lineage in vitro", Biochem Biophys Res Commun, 279, pp.500~504 (2000)
- Okano J, "Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K", AKT signaling pathway, 2003, pp.30, 298~304
- Shiota G, "In vivo transfer of hepatocyte growth factor gene accelerates proliferation of hepatic oval cells in a 2-acetylaminofluorene", partial hepatectomy model in rats, 2000, pp.470, 325~330
- Matsunaga T, "Expression of hepatocyte growth factor is up-regulated through activation of a cAMP-mediated pathway", Exp Cell Res, 210, pp.326~335 (1994)